<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.onhealthcare.tech/p/rydberg-blockade-optical-tweezers</loc><news:news><news:publication><news:name>Thoughts on Healthcare Markets &amp; Technology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-13T15:53:41+00:00</news:publication_date><news:title>Rydberg Blockade, Optical Tweezers, and the Long Road to Fault Tolerance: What Neutral Atom Quantum Computing Actually Means for Drug Discovery, Health Data Encryption, and Medical Sensing</news:title></news:news></url><url><loc>https://www.onhealthcare.tech/p/part-ii-rydberg-blockade-optical</loc><news:news><news:publication><news:name>Thoughts on Healthcare Markets &amp; Technology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-13T15:46:52+00:00</news:publication_date><news:title>Part II: Rydberg Blockade, Optical Tweezers, and the Long Road to Fault Tolerance: What Neutral Atom Quantum Computing Actually Means for Drug Discovery, Health Data Encryption, and Medical Sensing</news:title></news:news></url><url><loc>https://www.onhealthcare.tech/p/part-i-rydberg-blockade-optical-tweezers</loc><news:news><news:publication><news:name>Thoughts on Healthcare Markets &amp; Technology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-13T15:45:04+00:00</news:publication_date><news:title>Part I: Rydberg Blockade, Optical Tweezers, and the Long Road to Fault Tolerance: What Neutral Atom Quantum Computing Actually Means for Drug Discovery, Health Data Encryption, and Medical Sensing</news:title></news:news></url><url><loc>https://www.onhealthcare.tech/p/profluent-gemmabio-and-arpa-hs-160</loc><news:news><news:publication><news:name>Thoughts on Healthcare Markets &amp; Technology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-12T17:28:38+00:00</news:publication_date><news:title>Profluent, GEMMABio, and ARPA-H’s 160 Million Base Editor Moonshot: Why the AI-Designed Editor Was Never the Bottleneck and the FDA’s Plausible Mechanism Pathway Is the Real Bet</news:title></news:news></url><url><loc>https://www.onhealthcare.tech/p/profluent-gemmabio-and-arpa-h-s-160</loc><news:news><news:publication><news:name>Thoughts on Healthcare Markets &amp; Technology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-12T16:57:29+00:00</news:publication_date><news:title>Profluent, GEMMABio, and ARPA-H ‘s 160 Million Base Editor Moonshot: Why the AI-Designed Editor Was Never the Bottleneck and the FDA’s Plausible Mechanism Pathway Is the Real Bet</news:title></news:news></url></urlset>